RETRACTED: A Novel Method for Parkinson's Disease Diagnosis Utilizing Treatment Protocols (Retracted Article)

被引:5
|
作者
Al-Otaibi, Shaha [1 ]
Ayouni, Sarra [1 ]
Khan, Md Maruf Haque [2 ]
Badr, Malek [3 ,4 ]
机构
[1] Princess Nourah Bint Abdulrahman Univ, Coll Comp & Informat Sci, Dept Informat Syst, POB 84428, Riyadh 11671, Saudi Arabia
[2] Bangabandhu Sheikh Mujib Med Univ, Dept Publ Hlth & Informat, Dhaka, Bangladesh
[3] Univ Mashreq, Res Ctr, Baghdad, Iraq
[4] Al Farahidi Univ, Dept Med Instruments Engn Tech, Baghdad, Iraq
关键词
D O I
10.1155/2022/6871623
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
It makes no difference whether a person is male or female when it comes to neurodegenerative disorders; both sexes are equally susceptible to their devastating effects. Sometimes, it is unclear why a person in their life got a condition that is well-known in the world, such as Parkinson's disease. Other times, it is evident why the individual obtained the ailment (PD). In modern times, a variety of cutting-edge algorithms that are based on treatment protocols have been developed for the purpose of diagnosing Parkinson's disease. The approach that is presented in this article is the most current one; it was created using deep learning, and it can predict how severely Parkinson's disease would affect a patient. In order to diagnose this condition, it is necessary to conduct a comprehensive medical history, a history of any past treatments, physical exams, and certain blood tests and brain films. Because they are less time-consuming and costly, diagnoses are becoming an increasingly important part of medical practice. The diagnosis of Parkinson's disease by the physician is supported by the findings of the present research, which analyzed the voices of 253 participants. Preprocessing is done in order to get the most accurate results possible from the data. In order to carry out the technique of balancing, a methodical sampling approach was used to choose the data that would afterwards be evaluated. Using a feature selection approach that was determined by the magnitude of the label's influence, many data groups were created and organized. DT, SVM, and kNN are three methods that are used in classification algorithms and performance assessment criteria. The model was developed as a result of selecting the classification method and data group that had the greatest performance value. This decision led to the creation of the model. During the process of building the model, the SVM technique was used, and data comprising 45% of the original data set were utilized. The information was arranged in descending order of significance, beginning with the most pertinent. In addition to achieving exceptional outcomes in every other aspect of the project, the performance accuracy target was successfully met at 86 percent. As a consequence of this, it has been decided that the physician will be provided with medical decision support with the assistance of the data set obtained from the speech recordings of the individual who may have Parkinson's disease and the model that has been developed. This has led to the conclusion that medical decision support will be offered to the physician.
引用
收藏
页数:6
相关论文
共 50 条
  • [1] RETRACTED: Neuronal pathology in Parkinson's disease (Retracted Article)
    Schulz, JB
    Falkenburger, BH
    [J]. CELL AND TISSUE RESEARCH, 2004, 318 (01) : 135 - 147
  • [2] RETRACTED: Clinical Observation of Ropinirole Hydrochloride in the Treatment of Parkinson's Disease (Retracted Article)
    Zhang, JingZhou
    Gao, Xiaoli
    Chen, Yuan
    Kong, Qingxin
    [J]. COMPUTATIONAL AND MATHEMATICAL METHODS IN MEDICINE, 2022, 2022
  • [3] RETRACTED: Acupuncture in the Treatment of Parkinson's Disease with Sleep Disorders and Dose Response (Retracted Article)
    Li, Lihong
    Jin, Xiaoqing
    Cong, Wenjie
    Du, Tingting
    Zhang, Wei
    [J]. BIOMED RESEARCH INTERNATIONAL, 2022, 2022
  • [4] RETRACTED: Approach to ex vivo gene therapy in the treatment of Parkinson's disease (Retracted Article)
    Ishida, A
    Yasuzumi, F
    [J]. BRAIN & DEVELOPMENT, 2000, 22 : S143 - S147
  • [5] RETRACTED: Gantenerumab for the treatment of Alzheimer's disease (Retracted Article)
    Delrieu, Julien
    Ousset, Pierre Jean
    Vellas, Bruno
    [J]. EXPERT OPINION ON BIOLOGICAL THERAPY, 2012, 12 (08) : 1077 - 1086
  • [6] RETRACTED: Coenzyme Q10 for Parkinson's disease (Retracted Article)
    Liu, Jia
    Wang, Luning
    Zhan, Si-Yan
    Xia, Yinyin
    [J]. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2011, (12):
  • [7] RETRACTED: Role of Paeonol in an Astrocyte Model of Parkinson's Disease (Retracted Article)
    Ye, Maosheng
    Yi, Yuxin
    Wu, Shixing
    Zhou, Yong
    Zhao, Dongjie
    [J]. MEDICAL SCIENCE MONITOR, 2017, 23 : 4740 - 4748
  • [8] RETRACTED: Cardiovascular dysautonomia in de novo Parkinson's disease (Retracted Article)
    Oka, H
    Mochio, S
    Onouchi, K
    Morita, M
    Yoshioka, M
    Inoue, K
    [J]. JOURNAL OF THE NEUROLOGICAL SCIENCES, 2006, 241 (1-2) : 59 - 65
  • [9] RETRACTED: Cardiac involvement in malignant syndrome in Parkinson's disease (Retracted Article)
    Sato, Y
    Honda, Y
    Asoh, T
    Iwamoto, J
    Kanoko, T
    Satoh, K
    [J]. EUROPEAN NEUROLOGY, 2005, 54 (02) : 88 - 92
  • [10] RETRACTED: Study on Nano Drug Particles in the Diagnosis and Treatment of Alzheimer's Disease in the Elderly (Retracted Article)
    Li, ChangQing
    Xiang, Yu
    Wang, Yunqian
    Li, Ping
    [J]. BIOINORGANIC CHEMISTRY AND APPLICATIONS, 2022, 2022